209 related articles for article (PubMed ID: 9727052)
1. Secretory interleukin-1 receptor antagonist gene expression requires both a PU.1 and a novel composite NF-kappaB/PU.1/ GA-binding protein binding site.
Smith MF; Carl VS; Lodie T; Fenton MJ
J Biol Chem; 1998 Sep; 273(37):24272-9. PubMed ID: 9727052
[TBL] [Abstract][Full Text] [Related]
2. LPS-induced expression of the human IL-1 receptor antagonist gene is controlled by multiple interacting promoter elements.
Smith MF; Eidlen D; Arend WP; Gutierrez-Hartmann A
J Immunol; 1994 Oct; 153(8):3584-93. PubMed ID: 7930581
[TBL] [Abstract][Full Text] [Related]
3. Both PU.1 and nuclear factor-kappa B mediate lipopolysaccharide- induced HIV-1 long terminal repeat transcription in macrophages.
Lodie TA; Reiner M; Coniglio S; Viglianti G; Fenton MJ
J Immunol; 1998 Jul; 161(1):268-76. PubMed ID: 9647233
[TBL] [Abstract][Full Text] [Related]
4. Leptin activates the promoter of the interleukin-1 receptor antagonist through p42/44 mitogen-activated protein kinase and a composite nuclear factor kappa B/PU.1 binding site.
Dreyer MG; Juge-Aubry CE; Gabay C; Lang U; Rohner-Jeanrenaud F; Dayer JM; Meier CA
Biochem J; 2003 Mar; 370(Pt 2):591-9. PubMed ID: 12423202
[TBL] [Abstract][Full Text] [Related]
5. Regulation of IL-12 p40 promoter activity in primary human monocytes: roles of NF-kappaB, CCAAT/enhancer-binding protein beta, and PU.1 and identification of a novel repressor element (GA-12) that responds to IL-4 and prostaglandin E(2).
Becker C; Wirtz S; Ma X; Blessing M; Galle PR; Neurath MF
J Immunol; 2001 Sep; 167(5):2608-18. PubMed ID: 11509602
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 2 and 4 (TLR2 and TLR4) agonists differentially regulate secretory interleukin-1 receptor antagonist gene expression in macrophages.
Carl VS; Brown-Steinke K; Nicklin MJ; Smith MF
J Biol Chem; 2002 May; 277(20):17448-56. PubMed ID: 11877429
[TBL] [Abstract][Full Text] [Related]
7. Role of endogenous IL-10 in LPS-induced STAT3 activation and IL-1 receptor antagonist gene expression.
Carl VS; Gautam JK; Comeau LD; Smith MF
J Leukoc Biol; 2004 Sep; 76(3):735-42. PubMed ID: 15218058
[TBL] [Abstract][Full Text] [Related]
8. Roles of IFN consensus sequence binding protein and PU.1 in regulating IL-18 gene expression.
Kim YM; Kang HS; Paik SG; Pyun KH; Anderson KL; Torbett BE; Choi I
J Immunol; 1999 Aug; 163(4):2000-7. PubMed ID: 10438937
[TBL] [Abstract][Full Text] [Related]
9. Synergistic interactions between overlapping binding sites for the serum response factor and ELK-1 proteins mediate both basal enhancement and phorbol ester responsiveness of primate cytomegalovirus major immediate-early promoters in monocyte and T-lymphocyte cell types.
Chan YJ; Chiou CJ; Huang Q; Hayward GS
J Virol; 1996 Dec; 70(12):8590-605. PubMed ID: 8970984
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of a PU.1/Spi-B binding site in the bovine leukemia virus long terminal repeat.
Dekoninck A; Calomme C; Nizet S; de Launoit Y; Burny A; Ghysdael J; Van Lint C
Oncogene; 2003 May; 22(19):2882-96. PubMed ID: 12771939
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional activation of the human Galphai2 gene promoter through nuclear factor-kappaB and antioxidant response elements.
Arinze IJ; Kawai Y
J Biol Chem; 2005 Mar; 280(11):9786-95. PubMed ID: 15640523
[TBL] [Abstract][Full Text] [Related]
12. Functional synergism of STAT6 with either NF-kappa B or PU.1 to mediate IL-4-induced activation of IgE germline gene transcription.
Stütz AM; Woisetschläger M
J Immunol; 1999 Oct; 163(8):4383-91. PubMed ID: 10510379
[TBL] [Abstract][Full Text] [Related]
13. SB203580 enhances interleukin-1 receptor antagonist gene expression in IFN-gamma-stimulated BV2 microglial cells through a composite nuclear factor-kappaB/PU.1 binding site.
Park JS; Jung SH; Seo H; Kim HS
Neurosci Lett; 2007 Apr; 416(2):169-74. PubMed ID: 17316994
[TBL] [Abstract][Full Text] [Related]
14. NF beta A, a factor required for maximal interleukin-1 beta gene expression is identical to the ets family member PU.1. Evidence for structural alteration following LPS activation.
Buras JA; Reenstra WR; Fenton MJ
Mol Immunol; 1995 Jun; 32(8):541-54. PubMed ID: 7609733
[TBL] [Abstract][Full Text] [Related]
15. Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB.
Yu Z; Zhang W; Kone BC
Biochem J; 2002 Oct; 367(Pt 1):97-105. PubMed ID: 12057007
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of intracellular IL-1 receptor antagonist gene by IL-1 alpha in primary mouse keratinocytes.
La E; Fischer SM
J Immunol; 2001 May; 166(10):6149-55. PubMed ID: 11342635
[TBL] [Abstract][Full Text] [Related]
17. A NF-kappaB p65 subunit is indispensable for activating manganese superoxide: dismutase gene transcription mediated by tumor necrosis factor-alpha.
Maehara K; Hasegawa T; Isobe KI
J Cell Biochem; 2000 Apr; 77(3):474-86. PubMed ID: 10760955
[TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharide and Raf-1 kinase regulate secretory interleukin-1 receptor antagonist gene expression by mutually antagonistic mechanisms.
Guthridge CJ; Eidlen D; Arend WP; Gutierrez-Hartmann A; Smith MF
Mol Cell Biol; 1997 Mar; 17(3):1118-28. PubMed ID: 9032239
[TBL] [Abstract][Full Text] [Related]
19. Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: evidence of functional synergy between C/EBP and Rel proteins.
Plevy SE; Gemberling JH; Hsu S; Dorner AJ; Smale ST
Mol Cell Biol; 1997 Aug; 17(8):4572-88. PubMed ID: 9234715
[TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide suppresses RANK gene expression in macrophages by down-regulating PU.1 and MITF.
Ishii J; Kitazawa R; Mori K; McHugh KP; Morii E; Kondo T; Kitazawa S
J Cell Biochem; 2008 Oct; 105(3):896-904. PubMed ID: 18759249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
